PARP inhibitor tilts cell death from necrosis to apoptosis in cancer cells.
Ye
Keqiang
K
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, 615 Michael Street, Atlanta, Georgia 30322, USA. kye@emory.edu
D000477:Alkylating Agents / Q000494:pharmacology; D000818:Animals; D017209:Apoptosis; D016923:Cell Death; D045744:Cell Line, Tumor; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006367:HeLa Cells; D006801:Humans; D008769:Methylnitronitrosoguanidine / Q000494:pharmacology; D051379:Mice; D008928:Mitochondria / Q000378:metabolism; D008954:Models, Biological; D009336:Necrosis; D009474:Neurons / Q000378:metabolism; D000067856:Poly(ADP-ribose) Polymerase Inhibitors
D000477:Alkylating Agents; D004791:Enzyme Inhibitors; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D008769:Methylnitronitrosoguanidine